Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-19-021592
Filing Date
2019-10-31
Accepted
2019-10-31 11:38:10
Documents
18

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT f424b3103019_aptorumgroup.htm 424B3 2759486
2 GRAPHIC img_001.jpg GRAPHIC 24487
3 GRAPHIC img_002.jpg GRAPHIC 134401
4 GRAPHIC img_003.jpg GRAPHIC 129535
5 GRAPHIC img_004.jpg GRAPHIC 580758
6 GRAPHIC img_005.jpg GRAPHIC 134401
7 GRAPHIC img_006.jpg GRAPHIC 172900
8 GRAPHIC img_007.jpg GRAPHIC 89864
9 GRAPHIC img_008.jpg GRAPHIC 139270
10 GRAPHIC img_009.jpg GRAPHIC 171032
11 GRAPHIC img_010.jpg GRAPHIC 307301
12 GRAPHIC img_011.jpg GRAPHIC 703251
13 GRAPHIC img_012.jpg GRAPHIC 480016
14 GRAPHIC img_013.jpg GRAPHIC 573480
15 GRAPHIC img_014.jpg GRAPHIC 171129
16 GRAPHIC fin_001.jpg GRAPHIC 14024
17 GRAPHIC fin_002.jpg GRAPHIC 15024
18 GRAPHIC fin_003.jpg GRAPHIC 5583
  Complete submission text file 0001213900-19-021592.txt   8059583
Mailing Address 17/F, GUANGDONG INVESTMENT TOWER 148 CONNAUGHT ROAD CENTRAL HONG KONG F4 999077
Business Address 17/F, GUANGDONG INVESTMENT TOWER 148 CONNAUGHT ROAD CENTRAL HONG KONG F4 999077 852 2117 6611
Aptorum Group Ltd (Filer) CIK: 0001734005 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-232510 | Film No.: 191182600
SIC: 2834 Pharmaceutical Preparations